Jim Cramer Calls Medline the “Best IPO of the Year”

Medline Inc. (NASDAQ:MDLN) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. A caller asked if they should buy the stock, and Cramer replied, “I like that. Yes, yes. That is probably the best IPO of the year.”

A stock market data. Photo by AlphaTradeZone on Pexels

Medline Inc. (NASDAQ:MDLN) supplies medical and surgical products for hospitals, surgery centers, and other healthcare facilities. During the January 16 episode, a caller asked about the stock and mentioned that they started their position at $39. The Mad Money host said:

I’m going to tell you about Medline. That stock is unbelievable. I think it is a [buy, buy, buy, buy, buy, buy, buy, buy, buy]. That’s nine buys, just for the record.

While we acknowledge the risk and potential of MDLN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than MDLN and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1